Clinical trial NCT06271421 - References

Glioblastoma Multiforme — NanoTherm In Adjuvant Therapy of Glioblastoma Multiforme

Citation(s)

•   Barker CA, Chang M, Chou JF, Zhang Z, Beal K, Gutin PH, Iwamoto FM
  Radiotherapy and concomitant temozolomide may improve survival of elderly patients with glioblastoma. J Neurooncol. 2012 Sep;109(2):391-7. doi: 10.1007/s11060-012-0906-4. Epub 2012 Jun 12.
•   Boroon MP, Ayani MB, Bazaz SR
  Estimation of the optimum number and location of nanoparticle injections and the specific loss power for ideal hyperthermia. J Therm Biol. 2018 Feb;72:127-136. doi: 10.1016/j.jtherbio.2018.01.010. Epub 2018 Jan 31.
•   Curran WJ Jr, Scott CB, Horton J, Nelson JS, Weinstein AS, Fischbach AJ, Chang CH, Rotman M, Asbell SO, Krisch RE, et al
  Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials. J Natl Cancer Inst. 1993 May 5;85(9):704-10. doi: 10.1093/jnci/85.9.704.
•   Dong X, Noorbakhsh A, Hirshman BR, Zhou T, Tang JA, Chang DC, Carter BS, Chen CC
  Survival trends of grade I, II, and III astrocytoma patients and associated clinical practice patterns between 1999 and 2010: A SEER-based analysis. Neurooncol Pract. 2016 Mar;3(1):29-38. doi: 10.1093/nop/npv016. Epub 2015 Jul 1.
•   Grauer O, Jaber M, Hess K, Weckesser M, Schwindt W, Maring S, Wolfer J, Stummer W
  Combined intracavitary thermotherapy with iron oxide nanoparticles and radiotherapy as local treatment modality in recurrent glioblastoma patients. J Neurooncol. 2019 Jan;141(1):83-94. doi: 10.1007/s11060-018-03005-x. Epub 2018 Dec 1.
•   Gupta R, Sharma D
  Evolution of Magnetic Hyperthermia for Glioblastoma Multiforme Therapy. ACS Chem Neurosci. 2019 Mar 20;10(3):1157-1172. doi: 10.1021/acschemneuro.8b00652. Epub 2019 Feb 19.
•   Gupta T, Sarin R
  Poor-prognosis high-grade gliomas: evolving an evidence-based standard of care. Lancet Oncol. 2002 Sep;3(9):557-64. doi: 10.1016/s1470-2045(02)00853-7. Erratum In: Lancet Oncol 2002 Oct;3(10):592.
•   Hegi ME, Liu L, Herman JG, Stupp R, Wick W, Weller M, Mehta MP, Gilbert MR
  Correlation of O6-methylguanine methyltransferase (MGMT) promoter methylation with clinical outcomes in glioblastoma and clinical strategies to modulate MGMT activity. J Clin Oncol. 2008 Sep 1;26(25):4189-99. doi: 10.1200/JCO.2007.11.5964.
•   Huang H, Yu K, Mohammadi A, Karanthanasis E, Godley A, Yu JS
  It's Getting Hot in Here: Targeting Cancer Stem-like Cells with Hyperthermia. J Stem Cell Transplant Biol. 2017;2(2):113. Epub 2017 Dec 29.
•   Laperriere N, Zuraw L, Cairncross G; Cancer Care Ontario Practice Guidelines Initiative Neuro-Oncology Disease Site Group
  Radiotherapy for newly diagnosed malignant glioma in adults: a systematic review. Radiother Oncol. 2002 Sep;64(3):259-73. doi: 10.1016/s0167-8140(02)00078-6.
•   Mahmoudi K, Bouras A, Bozec D, Ivkov R, Hadjipanayis C
  Magnetic hyperthermia therapy for the treatment of glioblastoma: a review of the therapy's history, efficacy and application in humans. Int J Hyperthermia. 2018 Dec;34(8):1316-1328. doi: 10.1080/02656736.2018.1430867. Epub 2018 Feb 6.
•   Maier-Hauff K, Ulrich F, Nestler D, Niehoff H, Wust P, Thiesen B, Orawa H, Budach V, Jordan A
  Efficacy and safety of intratumoral thermotherapy using magnetic iron-oxide nanoparticles combined with external beam radiotherapy on patients with recurrent glioblastoma multiforme. J Neurooncol. 2011 Jun;103(2):317-24. doi: 10.1007/s11060-010-0389-0. Epub 2010 Sep 16.
•   Nwokedi EC, DiBiase SJ, Jabbour S, Herman J, Amin P, Chin LS
  Gamma knife stereotactic radiosurgery for patients with glioblastoma multiforme. Neurosurgery. 2002 Jan;50(1):41-6; discussion 46-7. doi: 10.1097/00006123-200201000-00009.
•   Paszat L, Laperriere N, Groome P, Schulze K, Mackillop W, Holowaty E
  A population-based study of glioblastoma multiforme. Int J Radiat Oncol Biol Phys. 2001 Sep 1;51(1):100-7. doi: 10.1016/s0360-3016(01)01572-3.
•   Pinel S, Thomas N, Boura C, Barberi-Heyob M
  Approaches to physical stimulation of metallic nanoparticles for glioblastoma treatment. Adv Drug Deliv Rev. 2019 Jan 1;138:344-357. doi: 10.1016/j.addr.2018.10.013. Epub 2018 Nov 7.
•   Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, Lacombe D, Cairncross JG, Eisenhauer E, Mirimanoff RO; European Organisation for Research and Treatment of Cancer Brain Tumor and Radiotherapy Groups; National Cancer Institute of Canada Clinical Trials Group
  Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005 Mar 10;352(10):987-96. doi: 10.1056/NEJMoa043330.
•   Stupp R, Taillibert S, Kanner A, Read W, Steinberg D, Lhermitte B, Toms S, Idbaih A, Ahluwalia MS, Fink K, Di Meco F, Lieberman F, Zhu JJ, Stragliotto G, Tran D, Brem S, Hottinger A, Kirson ED, Lavy-Shahaf G, Weinberg U, Kim CY, Paek SH, Nicholas G, Bruna J, Hirte H, Weller M, Palti Y, Hegi ME, Ram Z
  Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma: A Randomized Clinical Trial. JAMA. 2017 Dec 19;318(23):2306-2316. doi: 10.1001/jama.2017.18718. Erratum In: JAMA. 2018 May 1;319(17):1824.
•   Sun J, Guo M, Pang H, Qi J, Zhang J, Ge Y
  Treatment of malignant glioma using hyperthermia. Neural Regen Res. 2013 Oct 15;8(29):2775-82. doi: 10.3969/j.issn.1673-5374.2013.29.009.

Application of Nanoparticles for Cyclic Hyperthermia In Adjuvant Therapy of gLioblastoma Multiforme (ANCHIALE)

Details for clinical trial NCT06271421